Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- FOMC minutes from July 28-29th meeting
Cardiovascular Systems (CSII) PT Lowered to $34 at Oppenheimer
February 3, 2022 12:54 PM ESTOppenheimer analyst Suraj Kalia lowered the price target on Cardiovascular Systems (NASDAQ: CSII) to $34.00 (from $40.00) while maintaining an Outperform rating following results.
... MoreCardiovascular Systems (CSII) Misses Q2 EPS by 10c
February 3, 2022 6:13 AM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.23), $0.10 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $59.13 million versus the consensus estimate of $63.17 million.
GUIDANCE:
Cardiovascular Systems sees FY2022 revenue of $235-245 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More